Sentences with phrase «etf ibb»

Not exact matches

Biotechnology stocks are continuing to struggle despite a brief rally in April, with major index funds such as the iShares NASDAQ Biotechnology Index (IBB) and the S&P Biotech ETF (XBI) down about 25 % year - to - date.

The iShares Nasdaq Biotechnology ETF (IBB) hit a high of $ 300.29 Thursday, and closed at $ 300.08, just below the $ 302.40 level hit in January.

Biotech investors seem to think so, boosting the IBB biotech ETF by more than 2 percent Monday, and the XBI (in which both Bioverativ and Juno are among the heaviest - weighted stocks) by 3.5 percent.

The iShares Nasdaq Biotechnology ETF (IBB) rose more than 2 percent Thursday to its highest level since January 2016.

The Nasdaq Biotechnology ETF, the IBB, is booming this year, up more than 11 percent as the S&P 500 has rallied nearly 7 percent.

One such ETF to put on your watchlist is iShares Nasdaq Biotech Index ($ IBB).

Given the increasing volume of this ETF, combined with ongoing relative strength in the healthcare sector, we expect IBB to soon break out to a new record high.

In today's stock pick video, we discuss the potential swing trade setups in 2 stocks and 2 ETFs: $ SPY, $ IBB, $ TPX, and $ MW.

The biggest gainer was iShares Nasdaq Biotechnology ETF ($ IBB), which broke out above its recent consolidation and cruised 1.5 % higher.

One ETF on our radar screen for potential pullback buy entry is iShares Nasdaq Biotech Index ($ IBB).

Regular subscribers of The Wagner Daily should note our clear, predefined trigger, stop, and target prices for the $ QQQ and $ IBB trade setups in the ETF Trading Watchlist section of today's report.

To gain exposure to health care or biotech companies, investors may want to take a look at the iShares Nasdaq Biotechnology ETF (IBB) or the iShares U.S. Healthcare ETF (IYH).

iShares NASDAQ Biotechnology ETF ($ IBB) About five years ago, iShares NASDAQ Biotechnology ETF ($ IBB) kicked off a -LSB-...]

About five years ago, iShares NASDAQ Biotechnology ETF ($ IBB) kicked off a massive uptrend that lasted 3 1/2 years and led to a 400 % gain.

The iShares Nasdaq Biotechnology ETF (IBB) plummeted 6.

Once you look at the group — using iShares Nasdaq Biotechnology ETF (IBB) as a proxy, the performance is just cosmetic.

The sustained sell - off lead to the entire cohort to sell off from all - time highs of $ 132 to $ 83 or 37 % in only 6 months as measured via the iShares Nasdaq Biotechnology ETF (IBB).

The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB), an ETF that holds a diverse set of stocks from the biotechnology sector, is also off by more than 2 % in afternoon trading.

After a couple of tough years in 2015 and 2016, biotech stocks made a comeback in 2017 and are off to a strong start in 2018, with the iShares NASDAQ Biotechnology ETF (NASDAQ: IBB) up 10 % year to date already.

Instead, I think a well - diversified ETF like the iShares Nasdaq Biotechnology Index, or the IBB for short, is the actually best way to gain exposure to this ultra-high growth industry.

Recently, the fund's three largest equivalent positions were in the iShares Russell Mid-Cap Growth ETF (IWP; weight of about 41 %), iShares Nasdaq Biotechnology ETF (IBB; 24 %), and Vanguard Energy ETF (VDE; 23.6 %).

I recently highlighted the breakout in the SPDR S&P Biotech (ETF)(NYSEARCA: XBI) and the iShares Nasdaq Biotechnology Index (ETF)(NASDAQ: IBB) and concluded that any and all price dips should be viewed as buying opportunities.

Biotech ETF XBI (and IBB) recently began showing relative strength versus the broad US market.

The fund had top equivalent positions in the Vanguard Information Technology ETF (VGT; average weight of 53.8 %), iShares North American Tech - Software ETF (IGV; 15.1 %), iShares North American Tech - Multimedia Networking ETF (IGN; 13.1 %), iShares S&P Mid-Cap 400 Value ETF (IJJ; 7.5 %), iShares Morningstar Small - Cap ETF (JKJ; 4.3 %), and iShares Nasdaq Biotechnology ETF (IBB; 3.2 %).

There are other ETFs that are linked to various other NASDAQ indexes, including funds like Fidelity «s (ONEQ, B +) and iShares «(IBB, B +).